Brioni, Jorge D.

(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): A novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization

Decker, M. W., Brioni, J. D., Sullivan, J. P., Buckley, M. J., Radek, R. J., Raszkiewicz, J. L., Kang, C. H., Kim, D. J., Giardina, W. J., & Wasicak, J. T. (1994) · The Journal of Pharmacology and Experimental Therapeutics

Nicotinic Acetylcholine Receptors StudyNeuroscience and Neuropharmacology Research

Cited by 180

Involvement of the amygdaloid complex in neuromodulatory influences on memory storage

McGaugh, J. L., Introini-Collison, I. B., Nagahara, A. H., Cahill, L., Brioni, J. D., & Castellano, C. (1990) · Neuroscience & Biobehavioral Reviews

Memory and Neural MechanismsMemory Processes and Influences

Cited by 117

Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets

Zhang, D., Saraf, A., Kolasa, T., Bhatia, P., Zheng, G. Z., Patel, M., Lannoye, G. S., Richardson, P., Stewart, A., Rogers, J. C., et al. (2007) · Neuropharmacology

Cannabis and Cannabinoid ResearchPharmacogenetics and Drug Metabolism

Cited by 99

ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys

Decker, M. W., Bannon, A. W., Curzon, P., Gunther, K. L., Brioni, J. D., Holladay, M. W., Lin, N.-H., Li, Y., Daanen, J. F., Buccafusco, J. J., et al. (1997) · The Journal of Pharmacology and Experimental Therapeutics

Nicotinic Acetylcholine Receptors StudyCholinesterase and Neurodegenerative Diseases

Cited by 88

Anxiolytic-like effects of the novel cholinergic channel activator ABT-418

Brioni, J. D., O'Neill, A. B., Kim, D. J., Buckley, M. J., Decker, M. W., & Arneric, S. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics

Nicotinic Acetylcholine Receptors StudyNeuroscience and Neuropharmacology Research

Cited by 77

Structure−Activity Studies on 2-Methyl-3-(2(S)-pyrrolidinylmethoxy)pyridine (ABT-089): An Orally Bioavailable 3-Pyridyl Ether Nicotinic Acetylcholine Receptor Ligand with Cognition-Enhancing Properties

Lin, N.-H., Gunn, D. E., Ryther, K. B., Garvey, D. S., Donnelly-Roberts, D. L., Decker, M. W., Brioni, J. D., Buckley, M. J., Rodrigues, A. D., Marsh, K. G., et al. (1997) · Journal of Medicinal Chemistry

Nicotinic Acetylcholine Receptors StudyCholinesterase and Neurodegenerative Diseases

Cited by 67